4004 Wesbrook Mall
Vancouver, BC V6T 2A3 Canada
Member Sector: Academic & Research Institutions
TRIUMF is Canada’s national laboratory for particle and nuclear physics. It is owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada with building capital funds provided by the Government of British Columbia. Its mission is: To make discoveries that address the most compelling questions in particle physics, nuclear physics, nuclear medicine, and materials science; To act as Canada’s steward for the advancement of particle accelerators and detection technologies; and To transfer knowledge, train highly skilled personnel, and commercialize research for the economic, social, environmental, and health benefit of all Canadians. TRIUMF was founded in 1968 by Simon Fraser University, the University of British Columbia (UBC), and the University of Victoria to meet research needs that no single university could provide. The University of Alberta joined the TRIUMF consortium almost immediately. There are currently seven full members and seven associate members from across Canada in the consortium that governs TRIUMF. Strengthened by long-standing partnerships with the Pacific Parkinson’s Research Centre at UBC and the BC Cancer Agency, TRIUMF is a major player in the field of nuclear medicine. TRIUMF has expertise in the production of medical isotopes using accelerators and targets as well as the radiochemistry of labeling and tracing biologically active molecules within the human body using Positron Emission Tomography (PET). The second PET scanner ever to be made in Canada was built by a TRIUMF-led research team. These types of real-time imaging techniques underpin the personalized-medicine revolution. TRIUMF also maintains and operates the only centre in Canada for the treatment of ocular melanoma (eye cancer) using precision proton beams.